Synergy CHC (SNYR) Research & Development (2015 - 2025)
Synergy CHC's (SNYR) quarterly Research & Development came in at $4.5 million in Q4 2025, up 16.33% year-on-year from $3.8 million in Q4 2024, and up 63.73% quarter-over-quarter from $2.7 million in Q3 2025.
Synergy CHC (SNYR) Research & Development (2015 - 2025) Analysis & Trends
Synergy CHC's Research & Development history runs 9 years deep, the most recent figure standing at $4.5 million for Q4 2025.
- On a quarterly basis, Research & Development rose 16.33% year-over-year to $4.5 million in Q4 2025; TTM through Dec 2025 was $13.1 million, a 1.13% increase from a year earlier, with the FY2025 full-year figure at $13.1 million, up 1.13% from the prior year.
- Research & Development rose to $4.5 million in Q4 2025 per SNYR's latest filing, from $2.7 million in the prior quarter.
- Across five years, Research & Development topped out at $4.7 million in Q4 2023 and bottomed at $2.5 million in Q3 2024.
- The 3-year median for Research & Development is $3.3 million (2024), against an average of $3.5 million.
- Across the five-year window, Research & Development slumped 41.67% in 2024 and rose 16.33% in 2025, its largest moves.
- Year by year, Research & Development stood at $4.7 million in 2023, then retreated by 17.47% to $3.8 million in 2024, then advanced by 16.33% to $4.5 million in 2025.
- Per Business Quant, the three latest SNYR Research & Development figures stand at $4.5 million (Q4 2025), $2.7 million (Q3 2025), and $3.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.74 Bn | 101.76 Bn | 4.04 Bn | - |
| 2 | Cencora | 60.70 Bn | 58.52 Bn | 3.59 Bn | - |
| 3 | Cardinal Health | 53.92 Bn | 49.98 Bn | 2.50 Bn | - |
| 4 | Henry Schein | 9.74 Bn | 9.60 Bn | 1.07 Bn | - |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -8.97 Mn |
| 7 | Accendra Health | 248.40 Mn | -88.48 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 228.64 Mn | 213.64 Mn | 8.15 Mn | 2.60 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Synergy CHC | 1.67 Mn | -1.06 Mn | 2.22 Mn | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.47 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 4.66 Mn |
| Sep 30, 2023 | 4.30 Mn |
| Mar 31, 2020 | 2.25 Mn |
| Dec 31, 2019 | 2.74 Mn |
| Sep 30, 2019 | 2.77 Mn |
| Jun 30, 2019 | 2.65 Mn |
| Mar 31, 2019 | 3.31 Mn |
| Dec 31, 2018 | 4.34 Mn |
| Sep 30, 2018 | 3.96 Mn |
| Jun 30, 2018 | 5.15 Mn |
| Mar 31, 2018 | 4.25 Mn |
| Dec 31, 2017 | 3.24 Mn |